Alfred L. Garfall, MD, opens a discussion underscoring the unmet needs in multiple myeloma.
ASCO 2024: Updates in Multiple Myeloma
Dr Garfall, MD, provides insights following results derived from the MajesTEC-1 study.
Dr Garfall, MD, provides further insights around the MajesTEC-1 study.
Alfred L. Garfall, MD, discusses long-term follow-up data from the MajesTEC-1 study presented at ASCO 2024.
Alfred L. Garfall, MD, discusses follow-up data from the DREAMM-8 study presented at ASCO 2024.
Alfred L. Garfall, MD, discusses his hopes for the future treatment landscape of multiple myeloma.
Advertisement
Advertisement
Trending on AJMC
1
Andes Hantavirus FAQs: What to Know as Quarantined Cruise Passengers Return Home
2
Rituximab Suppresses Clinical Relapses, MRI Activity in Pediatric MS
3
New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease
4
FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301
5